The object of the regulations – called the Dangerous Drugs (Cannabis Import and Export Licensing) Regulations, 2019 – is “to establish a comprehensive licensing regime to regulate the importation and exportation of ganja for medical, therapeutic or scientific purposes in conformity with the Single Convention on Narcotic Drugs 1961, as amended by the 1972 Protocol, and minimize the risk of the diversion of ganja in illicit traffic,” according to the draft.

Full report

EXCLUSIVE: Jamaica readies rules for commercial medical cannabis exports